Dayra Therapeutics
PrivateLast Round
Series A
Nov 24, 2025
Total Funding Raised
$90M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Dayra Therapeutics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in November 2025.
Dayra Therapeutics is a biotechnology company that develops oral macrocyclic peptide therapeutics. The company combines its macrocycle discovery platform with computational design and modeling to create novel macrocyclic peptides that selectively target disease-relevant proteins, with the goal of expanding treatment options and improving patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dayra Therapeutics Comparables
Compare Dayra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vilya | 85% | |
| Orbis Medicines | 84% | |
| Unnatural Products | 81% |
For institutional investors. Book with your work email.
Dayra Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Dayra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 24, 2025
$70M round led by Versant Ventures.
For institutional investors. Book with your work email.
Dayra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dayra Therapeutics's valuation, stock price, and market status.
Is Dayra Therapeutics a public or private company?
Dayra Therapeutics is a private company.
What is the current stock price of Dayra Therapeutics?
Dayra Therapeutics is a private company, so its shares have no public market price. Caplight tracks Dayra Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dayra Therapeutics worth (valuation)?
Valuation information for Dayra Therapeutics is not publicly available.
Can I buy Dayra Therapeutics stock?
Dayra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dayra Therapeutics's last funding round?
Dayra Therapeutics's most recent funding round was Series A on November 24, 2025.
Who are the main investors in Dayra Therapeutics?
Key investors in Dayra Therapeutics include Versant Ventures.
Will Dayra Therapeutics IPO soon?
No public IPO plans have been announced for Dayra Therapeutics.
How can I track Dayra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Dayra Therapeutics's shares on secondary markets.